Dublin, March 29, 2022 (GLOBE NEWSWIRE) -- The "Global Drug Delivery Solutions Market 2020-2031" report has been added to ResearchAndMarkets.com's offering.
A recent market report published on the drug delivery solutions market provides global industry analysis for 2015-2020 & forecast for 2020-2031.
The report offers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historical, as well as current growth parameters of the drug delivery solutions market, the growth prospects of the market are obtained with maximum precision.
Key Topics Covered:
1. Executive Summary
2. Market Overview
2.1. Market Definition
2.2. Market Taxonomy
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Key Success Factors
4.1. Product Adoption / Usage Analysis
4.2. Product USPs / Features
5. Global Drug Delivery Solutions Market Demand Analysis 2015-2020 and Forecast, 2021-2031
5.1. Historical Market Volume (Bn Units) Analysis, 2015-2020
5.2. Current and Future Market Volume (Bn Units) Projections, 2021-2031
5.3. Y-o-Y Growth Trend Analysis
6. Global Drug Delivery Solutions Market - Pricing Analysis
6.1. Regional Pricing Analysis, by Product
6.2. Pricing Break-up
6.3. Global Average Pricing Analysis Benchmark
7. Global Drug Delivery Solutions Market Demand (US$ Mn) Analysis 2015-2020 and Forecast, 2021-2031
7.1. Historical Market Value (US$ Mn) Analysis, 2015-2020
7.2. Current and Future Market Value (US$ Mn) Projections, 2021-2031
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Market Background
8.1. Global Packaging Market Overview
8.2. Global Plastic Packaging Market Overview
8.3. Global Flexible Packaging Market Overview
8.4. Global Rigid Packaging Market Outlook
8.5. Global Pharmaceutical Industry Outlook
8.6. Macro-Economic Factors & Co-relation Analysis
8.6.1. Global GDP
8.6.2. GDP Per Capita
8.6.3. Manufacturing Value Added
8.6.4. Rigid Packaging Industry
8.6.5. Packaging Industry
8.7. Forecast Factors - Relevance & Impact
8.7.1. GDP Growth
8.7.2. Segmental Revenue Growth of Key Players
8.7.3. Manufacturing Value Added Growth
8.7.4. Rigid Packaging Industry Growth
8.7.5. Packaging Industry Growth
8.8. Value Chain Analysis
8.8.1. Key Market Participants
8.8.1.1. Raw Material Suppliers
8.8.1.2. Drug Delivery Solutions/Format Manufacturers
8.8.1.3. End-users
8.8.2. Profitability Margin
8.9. Market Dynamics
8.9.1. Drivers
8.9.2. Restraints
8.9.3. Opportunity Analysis
9. Impact of COVID-19
9.1. Current Statistics and Probable Future Impact
9.2. Impact of COVID-19 on Drug Delivery Solutions Market
10. Global Drug Delivery Solutions Market Analysis 2015-2020 and Forecast 2021-2031, by Product
11. Global Drug Delivery Solutions Market Analysis 2015-2020 and Forecast 2021-2031, By Material
12. Global Drug Delivery Solutions Market Analysis 2015-2020 and Forecast 2021-2031, by Application
13. Global Drug Delivery Solutions Market Analysis 2015-2020 and Forecast 2021-2031, by Region
14. North America Drug Delivery Solutions Market Analysis 2015-2020 and Forecast 2021-2031
15. Latin America Drug Delivery Solutions Market Analysis 2015-2020 and Forecast 2021-2031
16. Europe Drug Delivery Solutions Market Analysis 2015-2020 and Forecast 2021-2031
17. South Asia Drug Delivery Solutions Market Analysis 2015-2020 and Forecast 2021-2031
18. East Asia Drug Delivery Solutions Market Analysis 2015-2020 and Forecast 2021-2031
19. Oceania Drug Delivery Solutions Market Analysis 2015-2020 and Forecast 2021-2031
20. Middle East and Africa Drug Delivery Solutions Market Analysis 2015-2020 and Forecast 2021-2031
21. Drug Delivery Solutions Market Country-wise Analysis and Forecast
22. Market Structure Analysis
22.1. Market Analysis, by Tier of Drug Delivery Solutions Companies
22.2. Market Share Analysis of Top Players
22.3. Market Presence Analysis
23. Competition Analysis
23.1. Competition Dashboard
23.2. Competition Benchmarking
23.3. Customer Deep Dive
23.3.1. Drug Manufacturers
(Key Customers)
23.3.1.1. Pfizer Inc.
23.3.1.2. GlaxoSmithKline (GSK) plc.
23.3.1.3. Sanofi
23.3.1.4. Roche Holding AG
23.3.1.5. Novartis AG
23.3.1.6. Allergan (Abbvie Inc.)
23.3.1.7. Johnson & Johnson
23.3.1.8. Merck & Co., Inc.
23.3.1.9. Sun Pharmaceutical Industries Ltd.
23.3.1.10. Cadila Healthcare
23.3.2. Drug Delivery Solutions Manufacturers
(Key Global Market Players)
23.3.3. Amcor Plc
23.3.3.1. Overview
23.3.3.2. Product Portfolio
23.3.3.3. Profitability by Market Segments
23.3.3.4. Sales Footprint
23.3.3.5. Strategy Overview
23.3.3.5.1. Marketing Strategy
23.3.3.5.2. Product Strategy
23.3.3.5.3. Channel Strategy
23.3.4. Schott AG
23.3.4.1. Overview
23.3.4.2. Product Portfolio
23.3.4.3. Profitability by Market Segments
23.3.4.4. Sales Footprint
23.3.4.5. Strategy Overview
23.3.4.5.1. Marketing Strategy
23.3.4.5.2. Product Strategy
23.3.4.5.3. Channel Strategy
23.3.5. Gerresheimer AG
23.3.5.1. Overview
23.3.5.2. Product Portfolio
23.3.5.3. Profitability by Market Segments
23.3.5.4. Sales Footprint
23.3.5.5. Strategy Overview
23.3.5.5.1. Marketing Strategy
23.3.5.5.2. Product Strategy
23.3.5.5.3. Channel Strategy
23.3.6. Berry Global, Inc.
23.3.6.1. Overview
23.3.6.2. Product Portfolio
23.3.6.3. Profitability by Market Segments
23.3.6.4. Sales Footprint
23.3.6.5. Strategy Overview
23.3.6.5.1. Marketing Strategy
23.3.6.5.2. Product Strategy
23.3.6.5.3. Channel Strategy
23.3.7. Klockner Pentaplast Group
23.3.7.1. Overview
23.3.7.2. Product Portfolio
23.3.7.3. Profitability by Market Segments
23.3.7.4. Sales Footprint
23.3.7.5. Strategy Overview
23.3.7.5.1. Marketing Strategy
23.3.7.5.2. Product Strategy
23.3.7.5.3. Channel Strategy
23.3.8. Becton, Dickinson and Company
23.3.8.1. Overview
23.3.8.2. Product Portfolio
23.3.8.3. Profitability by Market Segments
23.3.8.4. Sales Footprint
23.3.8.5. Strategy Overview
23.3.8.5.1. Marketing Strategy
23.3.8.5.2. Product Strategy
23.3.8.5.3. Channel Strategy
23.3.9. Ardagh Group S.A.
23.3.9.1. Overview
23.3.9.2. Product Portfolio
23.3.9.3. Profitability by Market Segments
23.3.9.4. Sales Footprint
23.3.9.5. Strategy Overview
23.3.9.5.1. Marketing Strategy
23.3.9.5.2. Product Strategy
23.3.9.5.3. Channel Strategy
23.3.10. West Pharmaceutical Service, Inc.
23.3.10.1. Overview
23.3.10.2. Product Portfolio
23.3.10.3. Profitability by Market Segments
23.3.10.4. Sales Footprint
23.3.10.5. Strategy Overview
23.3.10.5.1. Marketing Strategy
23.3.10.5.2. Product Strategy
23.3.10.5.3. Channel Strategy
23.3.11. Bilcare Limited
23.3.11.1. Overview
23.3.11.2. Product Portfolio
23.3.11.3. Profitability by Market Segments
23.3.11.4. Sales Footprint
23.3.11.5. Strategy Overview
23.3.11.5.1. Marketing Strategy
23.3.11.5.2. Product Strategy
23.3.11.5.3. Channel Strategy
23.3.12. Wipak Group
23.3.12.1. Overview
23.3.12.2. Product Portfolio
23.3.12.3. Profitability by Market Segments
23.3.12.4. Sales Footprint
23.3.12.5. Strategy Overview
23.3.12.5.1. Marketing Strategy
23.3.12.5.2. Product Strategy
23.3.12.5.3. Channel Strategy
23.3.13. Mondi Plc
23.3.13.1. Overview
23.3.13.2. Product Portfolio
23.3.13.3. Profitability by Market Segments
23.3.13.4. Sales Footprint
23.3.13.5. Strategy Overview
23.3.13.5.1. Marketing Strategy
23.3.13.5.2. Product Strategy
23.3.13.5.3. Channel Strategy
23.3.14. Sealed Air Corporation
23.3.14.1. Overview
23.3.14.2. Product Portfolio
23.3.14.3. Profitability by Market Segments
23.3.14.4. Sales Footprint
23.3.14.5. Strategy Overview
23.3.14.5.1. Marketing Strategy
23.3.14.5.2. Product Strategy
23.3.14.5.3. Channel Strategy
23.3.15. Constantia Flexibles
23.3.15.1. Overview
23.3.15.2. Product Portfolio
23.3.15.3. Profitability by Market Segments
23.3.15.4. Sales Footprint
23.3.15.5. Strategy Overview
23.3.15.5.1. Marketing Strategy
23.3.15.5.2. Product Strategy
23.3.15.5.3. Channel Strategy
23.3.16. Clondalkin Group Holdings B.V.
23.3.16.1. Overview
23.3.16.2. Product Portfolio
23.3.16.3. Profitability by Market Segments
23.3.16.4. Sales Footprint
23.3.16.5. Strategy Overview
23.3.16.5.1. Marketing Strategy
23.3.16.5.2. Product Strategy
23.3.16.5.3. Channel Strategy
23.3.17. West Rock Company
23.3.17.1. Overview
23.3.17.2. Product Portfolio
23.3.17.3. Profitability by Market Segments
23.3.17.4. Sales Footprint
23.3.17.5. Strategy Overview
23.3.17.5.1. Marketing Strategy
23.3.17.5.2. Product Strategy
23.3.17.5.3. Channel Strategy
23.3.18. UDG Healthcare plc
23.3.18.1. Overview
23.3.18.2. Product Portfolio
23.3.18.3. Profitability by Market Segments
23.3.18.4. Sales Footprint
23.3.18.5. Strategy Overview
23.3.18.5.1. Marketing Strategy
23.3.18.5.2. Product Strategy
23.3.18.5.3. Channel Strategy
23.3.19. Catalent, Inc.
23.3.19.1. Overview
23.3.19.2. Product Portfolio
23.3.19.3. Profitability by Market Segments
23.3.19.4. Sales Footprint
23.3.19.5. Strategy Overview
23.3.19.5.1. Marketing Strategy
23.3.19.5.2. Product Strategy
23.3.19.5.3. Channel Strategy
23.3.20. Sonocco Products Company
23.3.20.1. Overview
23.3.20.2. Product Portfolio
23.3.20.3. Profitability by Market Segments
23.3.20.4. Sales Footprint
23.3.20.5. Strategy Overview
23.3.20.5.1. Marketing Strategy
23.3.20.5.2. Product Strategy
23.3.20.5.3. Channel Strategy
23.3.21. Reike Corporation
23.3.21.1. Overview
23.3.21.2. Product Portfolio
23.3.21.3. Profitability by Market Segments
23.3.21.4. Sales Footprint
23.3.21.5. Strategy Overview
23.3.21.5.1. Marketing Strategy
23.3.21.5.2. Product Strategy
23.3.21.5.3. Channel Strategy
23.3.22. Adelphi Healthcare Packaging
(Asia Pacific based Key Market Players)
23.3.23. Nipro Corporation
23.3.24. Uflex Ltd.
23.3.25. ACG Pharmapack Pvt. Ltd.
23.3.26. Piramal Glass Limited
23.3.27. Parekhplast India Ltd.
23.3.28. Shandong Pharmaceutical Glass Co., Ltd.
23.3.29. Avesta Continental Pack
23.3.30. Shanghai Tongpeng Electric Material Co., Ltd.
23.3.31. Khemka Glass
23.3.32. TPAC Packaging India Private Limited (Sunpet)
24. Assumptions and Acronyms Used
25. Research Methodology
For more information about this report visit https://www.researchandmarkets.com/r/vldoju
